Medical - global

Moderna combination Covid, flu vaccine shows positive data (cnbc.com)

• Moderna on Wednesday said its combination vaccine targeting Covid and the flu will move to a final stage trial after showing positive results in an earlier study.
• The biotech company is hoping its shot, mRNA-1083, can win approval from regulators in 2025. 

...

Britain’s COVID-19 response inquiry enters a second phase with political decisions in the spotlight LONDON (AP) — Britain’s inquiry into the response to the coronavirus pandemic and its impact on the nation entered its second phase Tuesday, with political decision-making around major developments… PAN PYLAS, Associated Press WWTI - InformNNY.com

...

Study: Paxlovid cuts hospitalization, death only in at-risk COVID patients with weak immune systems seb_ra / iStock CIDRAP

...in JAMA Network Open, an observational Canadian study ties the antiviral drug combo nirmatrelvir-ritonavir (Paxlovid) to a lower risk of hospitalization or death only in very high-risk COVID-19 patients with weakened immune systems.

...

Sepsis associated with COVID-19 infections more common than thought Overall, SARS-CoV-2–associated sepsis was present in 28.2% of patients admitted with SARS-CoV-2. CIDRAP

...in JAMA Network Open, researchers provide new evidence that the prevalence of SARS-CoV-2–associated sepsis among hospitalized adults is higher than previously thought, but deaths from the condition became less frequent as the pandemic progressed.

...